Optimer Pharmaceuticals (OPTR) Posts Wider than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Net loss attributable to noncontrolling interest: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss attributable to noncontrolling interest: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) reported Q3 loss of ($0.57), $0.05 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $5.44 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
